BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tan HW, Xu YM, Qin SH, Chen GF, Lau ATY. Epigenetic regulation of angiogenesis in lung cancer. J Cell Physiol 2021;236:3194-206. [PMID: 33078404 DOI: 10.1002/jcp.30104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zeng Y, Fu BM. Resistance Mechanisms of Anti-angiogenic Therapy and Exosomes-Mediated Revascularization in Cancer. Front Cell Dev Biol 2020;8:610661. [PMID: 33363174 DOI: 10.3389/fcell.2020.610661] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li X, Li X, Zhang B, He B, Papaccio G. The Role of Cancer Stem Cell-Derived Exosomes in Cancer Progression. Stem Cells International 2022;2022:1-13. [DOI: 10.1155/2022/9133658] [Reference Citation Analysis]
3 Mabeta P, Hull R, Dlamini Z. LncRNAs and the Angiogenic Switch in Cancer: Clinical Significance and Therapeutic Opportunities. Genes 2022;13:152. [DOI: 10.3390/genes13010152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li S. Anlotinib: A Novel Targeted Drug for Bone and Soft Tissue Sarcoma. Front Oncol 2021;11:664853. [PMID: 34094958 DOI: 10.3389/fonc.2021.664853] [Reference Citation Analysis]
5 Li Y, Lin M, Wang S, Cao B, Li C, Li G. Novel Angiogenic Regulators and Anti-Angiogenesis Drugs Targeting Angiogenesis Signaling Pathways: Perspectives for Targeting Angiogenesis in Lung Cancer. Front Oncol 2022;12:842960. [PMID: 35372042 DOI: 10.3389/fonc.2022.842960] [Reference Citation Analysis]